Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Studies on Anti-addictive Therapeutic Effects of Mirtazapine in Human Subjects Addicted to Cocaine.

NCT01949571 is registered in ClinicalTrials.gov with Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente as lead sponsor.

NCT NCT01949571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01949571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Studies on Anti-addictive Therapeutic Effects of Mirtazapine in Human Subjects Addicted to Cocaine.
Lead sponsor
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2007
Completion date
September 30, 2012
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aod craving, aodr depressive state, drug abuse, drug-induced depressive state, drug-withdrawal.